Sinopharm Group Co Ltd 2023 SR
The report highlights Sinopharm Group's sustainability performance for 2023, marking its 20th anniversary. The company maintained an MSCI ESG rating of A and was included in the Hang Seng Central Enterprises ESG Leading Index. It advanced its digital transformation through the 'Number One Project,' with several subsidiaries achieving high-tech certifications. Environmentally, the group neared completion of its first carbon-neutral demonstration zone and implemented a green logistics strategy. Socially, it focused on medical accessibility for rare diseases and achieved a 100% employee training rate.
Company: Sinopharm Group Co Ltd
Sector: Health Care
Country: China
Year: 2023
Type: SR
Pages: 51
Sinopharm Group Co Ltd
Sustainability Report
The report highlights Sinopharm Group's sustainability performance for 2023, marking its 20th anniversary. The company maintained an MSCI ESG rating of A and was included in the Hang Seng Central Enterprises ESG Leading Index. It advanced its digital transformation through the 'Number One Project,' with several subsidiaries achieving high-tech certifications. Environmentally, the group neared completion of its first carbon-neutral demonstration zone and implemented a green logistics strategy. Socially, it focused on medical accessibility for rare diseases and achieved a 100% employee training rate.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2023
Reporting Period
Jan 1, 2023 - Dec 31, 2023
Fiscal Year
2023
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Sustainable Development Goals
Other Standards
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Net Zero Target
Employees